AGP Executive Report
Last update: 2 hours agoCBD Business: York-based HempWell agreed to a multi-million-pound investment deal with JJ Double Gold, funding a new manufacturing facility and gummy line as it expands beyond CBD into wellness and sports recovery. Cannabis Regulation: The DEA denied Colorado firm MedPharm Research a federal bulk-manufacturer license, highlighting the gap between state authorization and federal requirements. Industry Deal: Curaleaf is challenging Aurora’s rejection of its enhanced takeover proposal, arguing shareholders deserve a chance to consider its offer. Cannabis Science: A new chromosome-level cannabis genome study links inherited genetic differences to variation in medicinal compounds, including cannabinoids and terpenes. Consumer Health: Research suggests doubling THC does not double the feeling of intoxication, while a review of 44,312 surgical patients found cannabis use was associated with a 46% higher heart-attack risk around surgery; patients should tell their anesthesiologist about use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
